EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-drug resistance in newly diagnosed AIDS-lymphoma



Multi-drug resistance in newly diagnosed AIDS-lymphoma



JAIDS Journal of Acquired Immune Deficiency Syndromes 21(1): A32, May 1




(PDF 0-2 workdays service: $29.90)

Accession: 035349141

Download citation: RISBibTeXText



Related references

The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV/AIDS patients during 1999-2012 in South Korea. Journal of Clinical Virology 81(): 53-57, 2016

The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation. Aids Research and Human Retroviruses 29(2): 329-336, 2013

National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/AIDS in South Korea: 1999-2005. Journal of Acquired Immune Deficiency Syndromes 49(3): 237-242, 2008

Mitoguazone dihydrochloride in combination with low dose CHOP for the treatment of newly diagnosed AIDS-related lymphoma. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 14(4): A39, 1997

Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan. Antiviral Research 75(1): 75-82, 2006

Drug selection guided by known and newly diagnosed comorbidities in a multi-risk patient. Revue Medicale de Liege 63(11): 693-696, 2009

Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy. Journal of Geriatric Oncology 6(6): 470-478, 2016

A multi-center retrospective study of L-asparaginase-based regimens as first-line treatment in newly diagnosed extranodal NK/T-cell lymphoma. Zhonghua Xue Ye Xue Za Zhi 35(7): 614-618, 2015

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004. Virus Research 118(1-2): 156-163, 2006

Prevalence of CMV UL97 resistance mutations in the eyes of patients with AIDS and newly diagnosed CMV retinitis. IOVS 40(4): S189, March 15, 1999

Complete heart block and persistent lactic acidosis as an initial presentation of non-hodgkin lymphoma in a critically ill newly diagnosed AIDS patient. Case Reports in Critical Care 2014: 214970-214970, 2014

Cellular drug resistance in childhood AML on relapse is not higher than at first diagnosis In vitro resistance to platinum compounds might have predictive value for newly diagnosed patients. Leukemia (Basingstoke) 17(3): 675, March, 2003

Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. Journal of Clinical Oncology 27(21): 3503-3509, 2009

Deep Sequencing of HIV-1 RNA and DNA in Newly Diagnosed Patients with Baseline Drug Resistance Showed No Indications for Hidden Resistance and Is Biased by Strong Interference of Hypermutation. Journal of Clinical Microbiology 54(6): 1605-1615, 2016

Transmission of HIV-1 drug resistance among newly diagnosed patients in Poland. Przeglad Epidemiologiczny 61(1): 29-34, 2007